Frontage has acquired a 45 percent interest in BDM and now exclusively co-owns BDM along with Hangzhou Tigermed Consulting. BDM is an independent contract research organization specializing in biostatistics, data management and SAS programming.
"This acquisition strengthens our offering and will further enhance Frontage's position as a complete and personalized development services partner with specialized expertise," said Song Li, Ph.D., CEO at Frontage. "Frontage continues to grow our portfolio of capabilities to help clients reduce the time and cost of product development."
BDM will continue to operate independently under the leadership of Sam Liang, M.D., its founder and president. The acquisition is expected to enhance BDM's market position across the North American and Asian markets as well.
"This is a strategic combination of Frontage's clinical development expertise with our biometrics services," said Liang. "Both organizations will benefit by being able to offer clients a more comprehensive solution for clinical trial support."
Frontage Laboratories helps biopharmaceutical, generic and medical device product companies advance research and development with offerings — including bioanalytical, DMPK, clinical, CMC, data management and biometrics — spanning from discovery stages through late-stage clinical trials. Frontage is your full-service Phase I-IV partner, with more than 400 beds across four sites and staff located across North America and Asia. For more information, visit www.frontagelab.com.
About BDM Consulting
BDM Consulting, Inc., founded in 1999 by Dr. Sam Liang and headquartered in Summerset, New Jersey, is an independent CRO specializing in biostatistics. SAS programming, and data management. BDM is composed of a group of more than 35 critical talents/experts, who excel and stand out among their peers in the industry. Its clients and partners include pharmaceutical, biotechnology, medical device companies and CROs. Striving to high quality, BDM focuses on reducing the time, cost and risk of bringing new pharmaceutical products to market. For more information, visit www.bdmconsulting-inc.com.